169 related articles for article (PubMed ID: 29272721)
21. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors.
Levine RA; Forest T; Smith C
Vet Pathol; 2002 May; 39(3):372-8. PubMed ID: 12014501
[TBL] [Abstract][Full Text] [Related]
23. Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262.
Song K; Liu N; Yang Y; Qiu X
Tumour Biol; 2016 May; 37(5):6493-9. PubMed ID: 26634745
[TBL] [Abstract][Full Text] [Related]
24. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-210 is increased and it is required for dedifferentiation of osteosarcoma cell line.
Zhang H; Mai Q; Chen J
Cell Biol Int; 2017 Mar; 41(3):267-275. PubMed ID: 28032372
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression.
Wu D; Zhang H; Ji F; Ding W
Pathol Res Pract; 2019 Jan; 215(1):115-120. PubMed ID: 30396754
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
[TBL] [Abstract][Full Text] [Related]
28. miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R.
Liu SY; Deng SY; He YB; Ni GX
Biochem Biophys Res Commun; 2017 Jan; 482(4):987-993. PubMed ID: 27908732
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
Li Y; Liu J; Liu ZZ; Wei WB
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259
[TBL] [Abstract][Full Text] [Related]
30. MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt.
Ru N; Zhang F; Liang J; Du Y; Wu W; Wang F; Liu X
Gene; 2018 Mar; 645():163-169. PubMed ID: 29248580
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.
Wang W; Zhou X; Wei M
Oncotarget; 2015 Apr; 6(12):10297-308. PubMed ID: 25912304
[TBL] [Abstract][Full Text] [Related]
32. Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy.
Izadpanah S; Shabani P; Aghebati-Maleki A; Baghbani E; Baghbanzadeh A; Fotouhi A; Bakhshinejad B; Aghebati-Maleki L; Baradaran B
Biomed Pharmacother; 2019 Mar; 111():873-881. PubMed ID: 30841466
[TBL] [Abstract][Full Text] [Related]
33. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y
Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of miR-422a inhibits cell proliferation and invasion, and enhances chemosensitivity in osteosarcoma cells.
Liu M; Xiusheng H; Xiao X; Wang Y
Oncol Rep; 2016 Dec; 36(6):3371-3378. PubMed ID: 27779704
[TBL] [Abstract][Full Text] [Related]
35. Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma.
Deng N; Li L; Gao J; Zhou J; Wang Y; Wang C; Liu Y
Biochem Biophys Res Commun; 2018 Jan; 495(1):189-196. PubMed ID: 29117539
[TBL] [Abstract][Full Text] [Related]
36. miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1.
Wu P; Liang J; Yu F; Zhou Z; Tang J; Li K
Oncotarget; 2016 Jul; 7(27):42241-42251. PubMed ID: 27304058
[TBL] [Abstract][Full Text] [Related]
37. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
38. VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma.
Zhao D; Jia P; Wang W; Zhang G
Mol Cell Biochem; 2015 Feb; 400(1-2):87-95. PubMed ID: 25385479
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.
Wang Y; Zhang S; Xu Y; Zhang Y; Guan H; Li X; Li Y; Wang Y
Tumour Biol; 2016 Nov; 37(11):15211-15220. PubMed ID: 27683056
[TBL] [Abstract][Full Text] [Related]
40. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
